Niaj hnub (mRNA) Tshuag tau nce ntau npaum li 8% hnub Wednesday ua ntej daws qhov nce 5.8% tom qab nws tshaj tawm Cov txiaj ntsig zoo rau kev kho mob qog noj ntshav melanoma hnub ua ntej. Hnub Wednesday tus nqi dhia ua raws li ze li ntawm 20% nce hauv nws cov nqi Tshuag hnub Tuesday. Thiab rau hnub Wednesday, lub Kev txheeb ze zog (RS) Rating rau Moderna Tshuag tua txog 96, los ntawm 87 ib hnub ua ntej.
X
96 RS Rating txhais tau tias Moderna Tshuag tau ua tiav 96% ntawm tag nrho cov khoom lag luam, tsis hais txog kev lag luam, dhau 52 lub lis piam dhau los. Kev tshawb fawb kev lag luam qhia tau hais tias cov khoom lag luam zoo tshaj plaws feem ntau muaj 80 lossis zoo dua RS Rating thaum pib ntawm kev nce tshiab.
Nrhiav Rau Winning Stocks? Sim No Kev Yoojyim
Moderna Tshuag Tied To Messenger RNA Technology
Cov neeg mob uas tau txais Moderna tshuaj tiv thaiv kab mob qog noj ntshav, uas nws koom nrog Merck's (MRK) Kev kho mob qog noj ntshav Keytruda, yog 44% tsawg dua yuav rov qab los lossis tuag dua nrog Keytruda ib leeg. Keytruda yog tus qauv kho rau melanoma. Moderna Tshuag tam sim no suav hais tias txuas ntxiv thiab tawm ntawm kev yuav khoom tom qab tshem tawm 188.75 qhov yuav khoom hauv thawj theem khob nrog kov.
Saib yog tias Moderna Tshuag tsim cov qauv tshiab lossis ua raws li kev yuav khoom zoo li ib peb lub lis piam nruj los yog rub rov qab mus rau 50-hnub lossis 10-lub lim tiam txav nruab nrab.
Nws yog xyoo qus rau Moderna. Hauv lub quarter kawg ntawm 2021 nws tau tshaj tawm ntau dua 1,000% kev muag khoom txhua xyoo thiab cov nyiaj tau los loj hlob vim nws cov tshuaj tiv thaiv Covid. Los ntawm qhov ntawd nws dwindled mus rau "tsuas yog" 200% kev loj hlob ntawm peb lub hlis tom ntej thiab tom qab ntawd ib xyoo dhau ib xyoo poob hauv cov nyiaj tau los rau peb lub hlis tom ntej, ntawm 9% nce hauv cov nyiaj tau los. Kev muag khoom thiab cov txiaj ntsig tau poob qis thaum cov tshuaj tiv thaiv Covid ploj mus. Lub quarter dhau los, kev muag khoom thiab cov nyiaj tau los tsis zoo.
Yuav Diversification puas tau?
Cov lus nug tam sim no yog: Cov Moderna puas tuaj yeem ua kom muaj ntau haiv neeg los ntawm nws cov tshuaj tiv thaiv Covid nrog nws tus xa xov tshiab RNA, lossis mRNA, thev naus laus zis. Nws tau siv nws thawj zaug los tsim cov tshuaj tiv thaiv Covid thiab tam sim no sim siv nws los kho mob qog noj ntshav. Tab sis nws muaj kev sib tw nyuaj hauv kev ua lag luam ntawd.
Lub caij no, Moderna Tshuag tau txais qib 71 ntawm nws cov phooj ywg hauv Medical-Biomed / Biotech kev lag luam pawg. Catalyst Pharmaceuticals (CPRX), Genmab (GMAB) thiab Harmony Biosciences (HRMY) yog ib qho ntawm 5 cov khoom lag luam muaj txiaj ntsig zoo hauv pab pawg.
Thaum saib cov cov khoom lag luam zoo tshaj plaws los yuav thiab saib, nyob ze ntawm qhov muag ntawm qhov txheeb ze lub zog ntsuas. IBD qhov tshwj xeeb ntsuas ntsuas tus nqi txav nrog 1 (qhov phem tshaj) rau 99 (zoo tshaj) tau qhab nia. Cov qhab nia qhia tau hais tias yuav ua li cas cov khoom lag luam tus nqi ua tau zoo tshaj li ntawm 52 lub lis piam sib tw tawm tsam tag nrho lwm cov khoom lag luam hauv peb cov ntaub ntawv.
Thov ua raws James DeTar ntawm Twitter @JimDeTar
KOJ UA LI CAS:
Biotech Thiab Pharmaceutical Industry And Stock News
Cov Stocks No Puas Yog Qhia Cov Nqes Zog Sib Zog?
Vim Li Cas Koj Yuav Siv IBD Qhov Txheeb Ze Tus Zog Txheeb Ze?
Li Cas Cov Kab Mob Sib Zog Yuav Pab Tau Koj Txiav Txim Siab
Saib Yuav Ua Li Cas Thiaj Txo Txoj Kev Pheej Yig, nce paj peev nrog Viav Vias Kev Ua Lag Luam
Tau qhov twg los: https://www.investors.com/news/technology/stock-upgrades-moderna-shows-rising-relative-strength-2/?src=A00220&yptr=yahoo